Overview of the microarray data, stratified by age, cut-off for seropositivity, and study period (pre- versus post-pandemic).

For each group the seroprevalence, i.e. the fraction with a titer higher than the cut-off, is shown. Also shown are the seroprevalence differences between the post-and pre-pandemic samples.Overview of the microarray data, stratified by age, cut-off for seropositivity, and study period (pre- versus post-pandemic).

针对每个组别，均展示了血清阳性率（seroprevalence），即抗体滴度高于临界值（cut-off）的样本占比。同时还呈现了大流行后与大流行前样本的血清阳性率差值。本部分提供了按年龄、血清阳性临界值以及研究周期（大流行前与大流行后）分层的微阵列（microarray）数据概览。